Read More Healthcare Industry News Elanco (NYSE: ELAN) wins USDA nod for Befrena monoclonal antibody in canine dermatology Elanco wins USDA approval for Befrena to treat canine dermatitis. Find out how this boosts its antibody strategy and reshapes competition in pet health. bySrinathJanuary 1, 2026